Work

Phase I Study of On 01910.Na (rigosertib), a Multikinase PI3K Inhibitor in Relapsed/Refractory B-Cell Malignancies

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.1803.1803

Authors: Mark Roschewski, Mohammed Farooqui, Georg Aue, Clifton C. Mo, Janet Valdez, Susan Soto, Patricia Perez-Galan, Francois Wilhelm, Adrian Wiestner

Institutions: National Institutes of Health, National Cancer Institute, National Heart, Lung, and Blood Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Onconova Therapeutics (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590556880

FWCI: 0.418

Cites:

Cited by: 3

Related to: 10